Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under ABVC BIOPHARMA, INC. in our court records and SEC 8-K records (as of 2026-10-18).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Eugene Jiang (filed 2025-07-15).
Who is behind it
ABVC BIOPHARMA, INC.: incorporated in Nevada; business address in Fremont, California; industry Pharmaceutical Preparations (Form 8-K, 2026-08-27).
Officers and directors, each with the role and the filing that names them:
- Uttam Patil: Executive Officer (Form D, 2024-05-28)
- Eugene Jiang: Director (Form D, 2024-05-28)
- Leeds Chow: Director (Form D, 2024-05-28)
- Tsung-Shann (T.S.) Jiang: Director (Form D, 2024-05-28)
- Tsang Ming Jiang: Director (Form D, 2024-05-28)
- Chang-Jen Jiang: Director (Form D, 2024-05-28)
- Norimi Sakamoto: Director (Form D, 2024-05-28)
- Yen-Hsin Chou: Director (Form D, 2024-05-28)
- Hsin-Hui Miao: Director (Form D, 2024-05-28)
- Yoshinobu Odaira: Director (Form D, 2024-05-28)
- Che-Wei Hsu: Director (Form D, 2024-05-28)
- Shuling Jiang: Director (Form D, 2024-05-28)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2025-08-13 | Lind Global Fund Ii LP | 3.2% |
| Schedule 13D/A, 2025-07-15 | Eugene Jiang | 18.5% |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2024-05-28 | $750K | $750K |
| Form D, 2023-03-02 | $3.17M | $3.70M |
Latest IPO step: ABVC BIOPHARMA, INC. filed its final IPO prospectus (424B4, 2026-08-17).
IPO filings: 424B4, 2026-08-17, 424B4, 2026-08-17, 424B4, 2026-08-17, 424B4, 2026-08-17, 424B4, 2025-11-14.
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-08-27).
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/abvc-biopharma